Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bracha

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Expert Opinion on Biological Therapy|October 24, 2017
Gene therapy for inherited retinal and optic nerve degenerationsNicholas A Moore, Nuria Morral, Thomas A Ciulla, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|November 17, 2021
Proliferative retinopathy and retinal detachment in pediatric atypical hemolytic uremic syndromeZujaja Tauqeer, Kandace L Gollomp, Peter Bracha, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Fibroblast Growth Factor Receptor Inhibitor-Associated Multifocal Serous Retinal Detachments: A Case ReportDiana H Kim, Tian Xia, Peter Bracha, et al.
Retina (Philadelphia, Pa.)|December 14, 2020
Management of Diabetic Retinopathy in the Anti-Vascular Endothelial Growth Factor EraRobert M Carroll, Peter Bracha, Charles G Miller, et al.
Retina (Philadelphia, Pa.)|November 26, 2020
Diagnostic and Therapeutic ChallengesDrew Scoles, Peter Bracha, Tomas S Aleman, et al.
Expert Opinion on Biological Therapy|July 21, 2017
Gene therapy for age-related macular degenerationNicholas A Moore, Peter Bracha, Rehan M Hussain, et al.
Survey of Ophthalmology|September 9, 2017
The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A reviewPeter Bracha, Nicholas A Moore, Thomas A Ciulla, et al.
International Journal of Retina and Vitreous|January 5, 2023
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot studyLucas W Rowe, Robert J Minturn, Lauren A Burgett, et al.
Ophthalmic Epidemiology|October 10, 2024
Glucagon-Like Peptide-1 Receptor Agonists are Not Associated with an Increased Risk of Progressing to Vision-Threatening Diabetic RetinopathyZujaja Tauqeer, Peter Bracha, Peiying Hua, et al.
International Journal of Retina and Vitreous|February 17, 2021
Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot StudyRobert J Minturn, Peter Bracha, Margaret J Klein, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Expert Opinion on Biological Therapy|October 24, 2017
Gene therapy for inherited retinal and optic nerve degenerationsNicholas A Moore, Nuria Morral, Thomas A Ciulla, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|November 17, 2021
Proliferative retinopathy and retinal detachment in pediatric atypical hemolytic uremic syndromeZujaja Tauqeer, Kandace L Gollomp, Peter Bracha, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Fibroblast Growth Factor Receptor Inhibitor-Associated Multifocal Serous Retinal Detachments: A Case ReportDiana H Kim, Tian Xia, Peter Bracha, et al.
Retina (Philadelphia, Pa.)|December 14, 2020
Management of Diabetic Retinopathy in the Anti-Vascular Endothelial Growth Factor EraRobert M Carroll, Peter Bracha, Charles G Miller, et al.
Retina (Philadelphia, Pa.)|November 26, 2020
Diagnostic and Therapeutic ChallengesDrew Scoles, Peter Bracha, Tomas S Aleman, et al.
Expert Opinion on Biological Therapy|July 21, 2017
Gene therapy for age-related macular degenerationNicholas A Moore, Peter Bracha, Rehan M Hussain, et al.
Survey of Ophthalmology|September 9, 2017
The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A reviewPeter Bracha, Nicholas A Moore, Thomas A Ciulla, et al.
International Journal of Retina and Vitreous|January 5, 2023
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot studyLucas W Rowe, Robert J Minturn, Lauren A Burgett, et al.
Ophthalmic Epidemiology|October 10, 2024
Glucagon-Like Peptide-1 Receptor Agonists are Not Associated with an Increased Risk of Progressing to Vision-Threatening Diabetic RetinopathyZujaja Tauqeer, Peter Bracha, Peiying Hua, et al.
International Journal of Retina and Vitreous|February 17, 2021
Intravitreal sirolimus for persistent, exudative age-related macular degeneration: a Pilot StudyRobert J Minturn, Peter Bracha, Margaret J Klein, et al.
Pageof 3